Announced Fri, 24 Jul · 17:58 IST
Board meeting on 4 Aug 2026 to consider Q1 FY27 financial results
Results View source PDF
APLLTD · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
—1-day move
₹797.05
prior close
₹824.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-1.9-1.4—-0.7——————————
Up moveDown movePending
AI summary
Alembic Pharmaceuticals has informed the exchanges that its Board of Directors will meet on Tuesday, 4 August 2026 to consider and approve the unaudited financial results for the quarter ended 30 June 2026. The trading window for dealing in company securities, which has been closed since 1 July 2026, will reopen 48 hours after the results are declared.
Likely market impact
Routine procedural filing. Investors should watch for the Q1 results announcement on 4 August 2026, which may move the stock depending on the numbers.